DiaMedica Therapeutics Inc. (DMAC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    DiaMedica Therapeutics In...

    NASDAQ: DMAC · Real-Time Price · USD
    6.82
    -0.02 (-0.29%)
    At close: Sep 26, 2025, 1:14 PM

    DiaMedica Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 39K 30K 25K 24K
    Gross Profit
    		 -39K -30K -25K -24K
    Operating Income
    		 -26.68M -21.27M -14M -13.65M
    Interest Income
    		 2.3M n/a n/a n/a
    Pretax Income
    		 -24.41M -19.34M -13.65M -13.56M
    Net Income
    		 -24.44M -19.38M -13.68M -13.59M
    Selling & General & Admin
    		 7.62M 8.16M 6.16M 4.88M
    Research & Development
    		 19.06M 13.11M 7.84M 8.77M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 26.68M 21.27M 14M 13.65M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 26.68M 21.27M 14M 13.65M
    Income Tax Expense
    		 30K 43K 28K 28K
    Shares Outstanding (Basic)
    		 40.4M 32.57M 26.44M 20.77M
    Shares Outstanding (Diluted)
    		 40.4M 32.57M 26.44M 20.77M
    EPS (Basic)
    		 -0.6 -0.6 -0.52 -0.65
    EPS (Diluted)
    		 -0.6 -0.6 -0.52 -0.65
    EBITDA
    		 -24.38M -19.31M -13.98M -13.62M
    EBIT
    		 -24.41M -19.34M -13.65M -13.56M
    Depreciation & Amortization
    		 39K 30K 25K 24K

    Add to Watchlist